Felippe Borlot, MD, MSc, CSCN (EEG)
Dr. Felippe Borlot is a well-respected epileptologist with a strong focus on the transition of care for individuals with epilepsy from childhood to adulthood, as well as the genetics of epilepsy. He has published numerous studies on the challenges of caring for adults with childhood-onset seizures, the complexities of phenotype-genotype correlations in rare forms of epilepsy, and the diagnostic yield of genetic testing in individuals with pediatric-onset epilepsy. These findings have greatly contributed to the field and provide valuable insights for other researchers. Furthermore, his work has been recognized through awards such as the Canadian League Against Epilepsy Trainee Publication Award, a research grant, and travel grants from prestigious organizations such as the American Epilepsy Society and BioMarin.
- Adult Epilepsy
- Childhood Seizures
- Clinical Genetics
- Chromosomal Microarray
- Epilepsy Genetics
- Long-term Outcome
- Multigene Panels
- Pediatric Epilepsy
- Transition of Care
Dr. Felippe Borlot is a renowned epileptologist with extensive training in both adult and pediatric epileptology from the University of Toronto. He is currently an assistant professor at the Max Rady College of Medicine at the University of Manitoba and is based at the HSC Seizure Clinic. Dr. Borlot's passion for helping those living with epilepsy led him on a journey of dedicated training and research in this field.
Throughout his career, he has shown a remarkable commitment to advancing the understanding of epilepsy and improving the quality of life for those living with it. He has a decade-long publication history in the field, with a focus on the transition of care from childhood to adulthood in epilepsy and the genetics of epilepsy. He has published numerous studies that address the challenges faced by adults with childhood-onset seizures, the complexity of phenotype-genotype correlation in rare forms of epilepsy, and the diagnostic yield of chromosomal microarray and multigene panels in adults with pediatric-onset epilepsy.
In recognition of his contributions to the field of epilepsy, Dr. Borlot has received several prestigious awards, including the Canadian League Against Epilepsy Trainee Publication Award and research grants from the Division of Neurology at Toronto Western Hospital and the Division of Pediatric Neurology at the Hospital for Sick Children, University of Toronto. He has also been the recipient of travel grants from the American Epilepsy Society and BioMarin for his expert testimony at international conferences.
With his wealth of knowledge and passion for the field, Dr. Borlot continues to be a leader in the field of epilepsy research, dedicated to finding new and innovative solutions to help those living with epilepsy live full and fulfilling lives.
Clinical Fellowship in Pediatric Epilepsy (2018-2020), The Hospital for Sick Children, University of Toronto, Toronto, ON
Clinical Fellowship in Adult Epilepsy (2013-2015), Toronto Western Hospital, University of Toronto, Toronto, ON
Master of Science in Medicine Program (2012-2014), Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil; Field of Study: Clinical Genetics
Chief Resident in Pediatric Neurology Residency (2010-2011), University of Sao Paulo, Sao Paulo, Brazil
Pediatric Neurology Residency (2005-2010), University of Sao Paulo, Sao Paulo, Brazil
School of Medicine (1999-2004), Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória, Vitoria, Brazil
Canadian League Against Epilepsy (CLAE) Trainee Publication Award, Fellow or Post-Doctoral category (2021)
New Initiatives Program Research Grant (2013-2014), Division of Neurology at Toronto Western Hospital & Division of Pediatric Neurology at the Hospital for Sick Children, University of Toronto, Toronto, ON
Travel grant and selection for the American Epilepsy Society Fellows Program (2019); Complimentary AES meeting registration, AES membership and travel expenses covered, Baltimore
Travel grant and expert testimony from BioMarin (2013), 12th International Congress of Inborn Errors of Metabolism, Barcelona